Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

24 Stocks Moving in Wednesday's Pre-Market Session

Gainers

  • Boxed, Inc. (NYSE:BOXD) rose 38.3% to $1.95 in pre-market trading. Boxed reported that Director Andrew Pearson bought 150,000 shares at an average price of $1.82 per share.
  • Color Star Technology Co., Ltd. (NASDAQ:CSCW) rose 37.3% to $0.1541 in pre-market trading after declining around 14% on Tuesday.
  • Revlon, Inc. (NYSE:REV) rose 22.4% to $2.29 in pre-market trading after jumping around 60% on Tuesday.
  • Algoma Steel Group Inc. (NASDAQ:ASTL) rose 17.2% to $9.26 in pre-market trading after the company reported results for its fiscal fourth quarter and full year ended March 31, 2022.
  • Inpixon (NASDAQ:INPX) rose 15.1% to $0.1378 in pre-market trading after dipping around 17% on Tuesday.
  • Inhibikase Therapeutics, Inc. (NASDAQ:IKT) rose 11.3% to $0.98 in pre-market trading. Inhibikase Therapeutics recently announced advancement of IkT-148009 Phase 2 '201' program following the FDA review.
  • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) shares rose 9.6% to $0.7351 in pre-market trading. G Medical Innovations, last month, reported a $1 million buyback plan.
  • Porch Group, Inc. (NASDAQ:PRCH) rose 9% to $2.92 in pre-market trading after dropping over 9% on Tuesday.
  • Digital World Acquisition Corp. (NASDAQ:DWAC) shares rose 8.2% to $29.55 in pre-market trading. Digital World Acquisition has been working towards consummating its proposed business combination with Trump Media & Technology Group.
  • New Oriental Education & Technology Group Inc. (NYSE:EDU) rose 8% to $22.97 in pre-market trading after jumping 24% on Tuesday. JP Morgan recently upgraded the stock from Neutral to Overweight and raised its price target from $14 to $24.
  • MorphoSys AG (NASDAQ:MOR) shares rose 7.9% to $4.92 in pre-market trading. MorphoSys and Human Immunology Biosciences, Inc. (HIBio), a biotechnology company, have established an equity participation agreement and license agreements to allow HIBio to develop and commercialize MorphoSys’ felzartamab, an anti-CD38 antibody, and MOR210, an anti-C5aR1 antibody.
  • GoHealth, Inc. (NASDAQ:GOCO) rose 7.6% to $0.6889 in pre-market trading after gaining over 7% on Tuesday.
  • Waterdrop Inc. (NYSE:WDH) rose 6.9% to $1.70 in pre-market trading after reporting Q1 results.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.